**Abbreviation**



**Author details**

Ibrahim O. Alanazi<sup>1</sup>

(KACST), Saudi Arabia

**References**

prediction

237-249

474-482

614-619

1515-1538

\* and Zahid Khan<sup>2</sup>

1 National Center for Biotechnology, King Abdulaziz City for Science and Technology

Endocrine and Cell Surface Receptor Signaling in Breast Carcinogenesis

http://dx.doi.org/10.5772/intechopen.74679

119

2 Genome Research Chair, Department of Biochemistry, College of Science, King Saud

[1] Jemal A et al. Global cancer statistics. CA: A Cancer Journal for Clinicians. 2011;**61**(2):69-90

[2] Jemal A et al. Global patterns of cancer incidence and mortality rates and trends. Cancer

[3] Sarkar S, Mandal M. Breast cancer: Classification based on molecular etiology influencing prognosis and prediction. Gunduz PM. editor, In: Breast Cancer - Focusing Tumor Microenvironment, Stem cells and Metastasis, 2011. https://www.intechopen.com/ books/breast-cancer-focusing-tumor-microenvironment-stem-cells-and-metastasis/ breast-cancer-classification-based-on-molecular-etiology-influencing-prognosis-and-

[4] Kaminska M et al. Breast cancer risk factors. Prz Menopauzalny. 2015;**14**(3):196-202

[5] Anders CK et al. Breast cancer before age 40 years. Seminars in Oncology. 2009;**36**(3):

[6] Singletary SE. Rating the risk factors for breast cancer. Annals of Surgery. 2003;**237**(4):

[7] Malhotra GK et al. Histological, molecular and functional subtypes of breast cancers.

[8] Recommendations for the reporting of breast carcinoma. Association of Directors of Anatomic and Surgical Pathology. American Journal of Clinical Pathology. 1995;**104**(6):

[9] Lester SC et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Archives of Pathology & Laboratory Medicine. 2009;**133**(10):

[10] Barroso-Sousa R, Metzger-Filho O. Differences between invasive lobular and invasive ductal carcinoma of the breast: Results and therapeutic implications. Therapeutic Advances

Epidemiology, Biomarkers & Prevention. 2010;**19**(8):1893-1907

Cancer Biology & Therapy. 2010;**10**(10):955-960

in Medical Oncology. 2016;**8**(4):261-266

\*Address all correspondence to: ialenazi@kacst.edu.sa

University, Riyadh, Kingdom of Saudi Arabia
